Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04607200
Title AGEN2034 & AGEN1884 in Patients With Recurrent, Inoperable Angiosarcoma
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Agenus Inc.
Indications

angiosarcoma

Therapies

Balstilimab + Zalifrelimab

Balstilimab

Age Groups: adult | senior
Covered Countries


No variant requirements are available.